Recent News

• 06.11.2026 - Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
• 06.02.2026 - Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
• 05.20.2026 - Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
• 05.14.2026 - Co-Diagnostics Reports First Quarter 2026 Financial Results

Recent Filings

• 06.03.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.29.2026 - EFFECT Notice of Effectiveness
• 05.28.2026 - S-3 Registration statement under Securities Act of 1933
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 4 Statement of changes in beneficial ownership of securities